4//SEC Filing
Schoenberg Mark 4
Accession 0001437749-25-026377
CIK 0001668243other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 9:58 AM ET
Size
4.7 KB
Accession
0001437749-25-026377
Insider Transaction Report
Form 4
Schoenberg Mark
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2025-08-11$17.69/sh−10,000$176,900→ 148,229 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 and $17.76. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001763581
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 9:58 AM ET
- Size
- 4.7 KB